Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 122   

Articles published

GSK 1,445.15 +7.15 (0.50%)
price chart
GlaxoSmithKline hails progress with lung disease treatment
GlaxoSmithKline PLC (LON:GSK) and Innoviva Inc (NASDAQ:INVA) have taken a step forward with their potential treatment for chronic obstructive pulmonary disease (COPD).
GlaxoSmithKline (GSK) Stock to Gain on Lung Drug Success in UK Study  Bidness ETC
Are GlaxoSmithKline plc, Tissue Regenix Group plc and Optibiotix Health plc ...
City analysts forecast an earnings rise of 15%, and this is expected to be just the start of a new growth trajectory. As such, Glaxo appears an attractive buy at a current share price of 1,436p on a price-to-earnings ratio of 16.4 and with a dividend ...
Glaxosmithkline Plc (NYSE:GSK) Sellers Increased By 15.53% Their Shorts
The stock of Glaxosmithkline Plc (NYSE:GSK) registered an increase of 15.53% in short interest. GSK's total short interest was 4.00M shares in May as published by FINRA.
GlaxoSmithKline PLC (NYSE:GSK) Closes At $42.010  Investor Newswire
Broker Roundup For GlaxoSmithKline PLC (NYSE:GSK)  Share Trading News
Stock Trending Down: GlaxoSmithKline plc (NYSE:GSK)
GlaxoSmithKline plc (NYSE:GSK) stock has moved in a downward direction over the past month, causing some worry for investors.
Are Aviva plc, GlaxoSmithKline plc and Royal Dutch Shell plc the FTSE 100's ...
GlaxoSmithKline has seen earnings slide during the past four years as exclusivity lapses across key products have dented revenues growth.
Time to buy GlaxoSmithKline plc and Carillion plc?
Today I'll be taking a closer look at construction services company Carillion (LSE: CLLN), and pharmaceuticals giant GlaxoSmithKline (LSE: GSK). Is it the right time to invest in these Great British businesses?
Longer lives, bigger profits: Why I'm bullish on GlaxoSmithKline plc ...  AOL Money UK
You could beat the market with GlaxoSmithKline plc and Shire plc
GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) are two such companies. Shire is a world-leading producer of rare disease treatments, and the company is unlikely to be displaced from this position anytime soon.
Raymond James & Associates Increased Glaxosmithkline Plc (NYSE:GSK) by $14.25 ...
Raymond James & Associates increased its stake in Glaxosmithkline Plc (NYSE:GSK) by 13.1% based on its latest 2016Q1 regulatory filing with the SEC.
Healthcare Moving Stocks: Bristol-Myers Squibb Company (NYSE:BMY ...
In most recently trading session on 5/23/2016, GlaxoSmithKline PLC (NYSE:GSK) dropped +0.00% while traded on 1.63 million shares versus it's an average volume of 3.28 million shares.
Why is Neil Woodford so bullish on drugmakers GlaxoSmithKline plc, AstraZeneca ...
Neil Woodford's Equity Income Fund is heavily weighted towards healthcare companies, and GlaxoSmithKline (LSE: GSK) makes up 6.3% of this entire fund. Woodford hasn't only been buying the company for its 5%-plus dividend though, but also sees great ...